Diana Brainard - 04 Jan 2024 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role
Chief Executive Officer, Director
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
ALVR
Transactions as of
04 Jan 2024
Transactions value $
-$1,063
Form type
4
Filing time
08 Jan 2024, 16:15:11 UTC
Previous filing
21 Nov 2023
Next filing
25 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale -$1,063 -1,664 -0.19% $0.639 873,242 04 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.